Opus Genetics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Opus Genetics Inc
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Opus Genetics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Opus Genetics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Opus Genetics Inc is IRD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Opus Genetics Inc has its primary listing on NASDAQ. You can trade Opus Genetics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Opus Genetics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Opus Genetics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Opus Genetics Inc.